Skip to main content

Published locations for FDA approves secukinumab in psoriasis patients age six and older

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves secukinumab in psoriasis patients age six and older

User login

  • Reset your password
  • /content/fda-approves-secukinumab-psoriasis-patients-age-six-and-older
  • /edermatologynews/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and
  • /familypracticenews/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and
  • /pediatricnews/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and
  • /rheumatologynews/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and
  • /jcomjournal/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and-older
  • /pediatrics/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and-older
  • /rheumatology/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and-older
  • /dermatology/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and-older
  • /familymedicine/article/240980/pediatrics/fda-approves-secukinumab-psoriasis-patients-age-six-and